Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

NCT06051123

Conditions
ALS (Amyotrophic Lateral Sclerosis), ALSFTD, Amyotrophic Lateral Sclerosis, +12 more
Locations
  • Stan Cassidy Centre for Rehabilitation Fredericton, New Brunswick, Canada
  • Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada
  • University of Saskatchewan, Clinical Trials Support Unit Saskatoon, Saskatchewan, Canada
View Trial Details
Recruiting

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

NCT07369076

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Neuroscience Research Australia Randwick, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
  • Flinders Medical Centre Bedford Park, South Australia, Australia
View Trial Details
Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

NCT07002034

Conditions
Adjustment Disorder, Adjustment Disorders, Amyotrophic Lateral Sclerosis, +28 more
Locations
  • UAB, Psychiatry and Behavioral Neurology Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Kadima Neuropsychiatry Institute San Diego, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 32 locations
View Trial Details
Recruiting

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

NCT06351592

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +10 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Macquarie University Sydney, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • KU Leuven Leuven, Vlaams-Brabant, Belgium
View all 22 locations
View Trial Details
Recruiting

Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

NCT07287397

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • St Joseph's Hospital and medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego Medical Center San Diego, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Miami School of Science Miami, Florida, United States
View Trial Details

Related conditions